OraLiva was recently highlighted by CareQuest Innovation Partners in their SMILE Health program case study. The feature underscores how OraLiva’s AI-powered brush biopsy is addressing one of the most critical challenges in oral health: the late detection of oral cancer.
Key highlights from the case study
- Seamless integration: OraLiva fits directly into routine dental care with a simple, non-invasive procedure.
- AI-powered analysis: Leveraging over 13 million cell images to deliver lab-quality diagnostic accuracy in real time.
- Strategic partnerships: Collaborations with leaders like Delta Dental and Henry Schein to support adoption and access at scale.
Driving impact in oral health
Recognition from CareQuest Innovation Partners reflects OraLiva’s mission to make early cancer detection more accessible, efficient, and effective—empowering dental professionals to identify disease earlier and improve outcomes for patients everywhere.
